Market Cap 239.76M
Revenue (ttm) 0.00
Net Income (ttm) -15.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 855,299
Avg Vol 487,302
Day's Range N/A - N/A
Shares Out 237.38M
Stochastic %K 21%
Beta 1.63
Analysts Sell
Price Target $13.00

Company Profile

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis pat...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 2 620 8072
Address:
14 Einstein Street, Ness Ziona, Israel
Alex1710
Alex1710 Aug. 19 at 1:19 AM
$ENLV It's too bad I did not know this company before but with that change in becoming a tech company I would have shorted big time. I think it's still time to short. Yes I'll do that tomorrow for a quick buck.
0 · Reply
Alex1710
Alex1710 Aug. 19 at 1:00 AM
$ENLV This company is a joke. I don't understand the business model so I'll never invest. Enlivex Announces $400,000,000 Private Placement.
0 · Reply
JJRADANO
JJRADANO Aug. 18 at 11:43 PM
$ENLV Oren and Shai really screwed the shareholders. They're in bed with a big time crypto crook and the stock price is in the toilet. Thanks a lot.
0 · Reply
Sensore
Sensore Aug. 18 at 7:48 PM
0 · Reply
Alex1710
Alex1710 Aug. 18 at 4:25 PM
$ENLV 3 RS since the company exists. The SP performance is a real disaster. The CEO has to leave he has proven to be totally incompetent.
1 · Reply
Alex1710
Alex1710 Aug. 18 at 4:03 PM
$ENLV I'm new here don't need to tell that osteoarthritis ia a HUGE market but what I don't like is : Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem. You're a biotech company or a company operating in I don't know what. It totally confuse investors.
1 · Reply
Fishin_Fool
Fishin_Fool Aug. 17 at 3:12 PM
$DDD Gross margin fell YoY to 36.4% from 38.1%, which reads bearish but it fell because of hardware mix, not pricing. On a trailing basis GM has gone 33.9% (FY25) >> 35.9% (Q1) >>36.4% (Q2). Graves: "The key to profitability for us is getting our gross margins up. The linkage there is to consumables on the polymer side and metal parts on the metal side… we'll get material pull-through that almost assuredly always follows. In many cases, it's a regulated environment and it has to follow." $ENLV $KOS $HNST $STKH
2 · Reply
TakeWhatYouGet
TakeWhatYouGet Aug. 14 at 3:53 PM
$ENLV out... Have fun Guys
0 · Reply
Sensore
Sensore Aug. 14 at 3:31 PM
0 · Reply
JJRADANO
JJRADANO Aug. 14 at 3:03 PM
$ENLV When is the vote? Looks like there is doubt about vote and/or clinical trial?
1 · Reply
Latest News on ENLV
Enlivex Registration statement: Registration filing

Aug 6, 2026, 8:00 AM EDT - 13 days ago

Enlivex Registration statement: Registration filing


Enlivex Transcript: Study update

Jul 30, 2026, 10:00 AM EDT - 19 days ago

Enlivex Transcript: Study update


Enlivex Therapeutics announces $400M private placement

2026-07-28T12:36:35.000Z - 22 days ago

Enlivex Therapeutics announces $400M private placement


Enlivex Announces $400,000,000 Private Placement

Jul 28, 2026, 8:00 AM EDT - 22 days ago

Enlivex Announces $400,000,000 Private Placement


Enlivex Therapeutics trading halted, news pending

2026-07-08T23:50:17.000Z - 5 weeks ago

Enlivex Therapeutics trading halted, news pending


Enlivex Therapeutics announces 1-for-15 reverse split

2026-07-07T12:36:17.000Z - 6 weeks ago

Enlivex Therapeutics announces 1-for-15 reverse split


Enlivex Slides: Investor presentation

Jun 24, 2026, 9:00 AM EDT - 7 weeks ago

Enlivex Slides: Investor presentation


Enlivex Therapeutics announces issuance of Australian patent

2026-06-15T13:01:02.000Z - 2 months ago

Enlivex Therapeutics announces issuance of Australian patent


Enlivex Slides: Investor presentation

Jun 15, 2026, 7:00 AM EDT - 2 months ago

Enlivex Slides: Investor presentation


Enlivex Therapeutics doses first patient in Allocetra trial

2026-05-18T12:17:18.000Z - 3 months ago

Enlivex Therapeutics doses first patient in Allocetra trial


Enlivex Registration statement: Registration filing

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Enlivex Registration statement: Registration filing


Ondo Global Markets Tokenizes Enlivex's Ordinary Shares

Apr 8, 2026, 8:30 AM EDT - 4 months ago

Ondo Global Markets Tokenizes Enlivex's Ordinary Shares


Enlivex Earnings Call Transcript: Q4 2025

Mar 25, 2026, 9:00 AM EDT - 5 months ago

Enlivex Earnings Call Transcript: Q4 2025


Enlivex Annual report: Q4 2025

Mar 25, 2026, 9:00 AM EDT - 5 months ago

Enlivex Annual report: Q4 2025


Enlivex Quarterly report: Q4 2025

Mar 25, 2026, 9:00 AM EDT - 5 months ago

Enlivex Quarterly report: Q4 2025


Enlivex Slides: Investor presentation

Mar 24, 2026, 8:00 AM EDT - 5 months ago

Enlivex Slides: Investor presentation


Enlivex Therapeutics management to meet virtually with BTIG

2026-02-18T17:40:32.000Z - 6 months ago

Enlivex Therapeutics management to meet virtually with BTIG


Enlivex Therapeutics shares to trade exclusively on Nasdaq

2026-01-23T13:05:21.000Z - 7 months ago

Enlivex Therapeutics shares to trade exclusively on Nasdaq


Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

Jan 23, 2026, 8:00 AM EST - 7 months ago

Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq


Enlivex Registration statement: Registration Filing

Dec 23, 2025, 7:00 AM EST - 8 months ago

Enlivex Registration statement: Registration Filing


Enlivex Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 9 months ago

Enlivex Quarterly report: Q3 2025


Enlivex Quarterly report: Q2 2025

Aug 29, 2025, 4:00 PM EDT - 1 year ago

Enlivex Quarterly report: Q2 2025


Enlivex Transcript: Status Update

Aug 18, 2025, 8:00 AM EDT - 1 year ago

Enlivex Transcript: Status Update


Enlivex Press release: Status Update

Aug 18, 2025, 8:00 AM EDT - 1 year ago

Enlivex Press release: Status Update


Enlivex Slides: Company Presentation

Jun 3, 2025, 6:00 PM EDT - 1 year ago

Enlivex Slides: Company Presentation


Enlivex Earnings release: Q1 2025

May 29, 2025, 6:00 PM EDT - 1 year ago

Enlivex Earnings release: Q1 2025


Enlivex Selected to Present at Israeli BioMed 2025 Conference

May 20, 2025, 8:00 AM EDT - 1 year ago

Enlivex Selected to Present at Israeli BioMed 2025 Conference


Enlivex Registration statement: Registration Filing

May 2, 2025, 8:00 AM EDT - 1 year ago

Enlivex Registration statement: Registration Filing


Enlivex Annual report: Q4 2024

Apr 29, 2025, 6:00 PM EDT - 1 year ago

Enlivex Annual report: Q4 2024


Enlivex Slides: Company Presentation

Mar 6, 2025, 7:00 AM EST - 1 year ago

Enlivex Slides: Company Presentation


Alex1710
Alex1710 Aug. 19 at 1:19 AM
$ENLV It's too bad I did not know this company before but with that change in becoming a tech company I would have shorted big time. I think it's still time to short. Yes I'll do that tomorrow for a quick buck.
0 · Reply
Alex1710
Alex1710 Aug. 19 at 1:00 AM
$ENLV This company is a joke. I don't understand the business model so I'll never invest. Enlivex Announces $400,000,000 Private Placement.
0 · Reply
JJRADANO
JJRADANO Aug. 18 at 11:43 PM
$ENLV Oren and Shai really screwed the shareholders. They're in bed with a big time crypto crook and the stock price is in the toilet. Thanks a lot.
0 · Reply
Sensore
Sensore Aug. 18 at 7:48 PM
0 · Reply
Alex1710
Alex1710 Aug. 18 at 4:25 PM
$ENLV 3 RS since the company exists. The SP performance is a real disaster. The CEO has to leave he has proven to be totally incompetent.
1 · Reply
Alex1710
Alex1710 Aug. 18 at 4:03 PM
$ENLV I'm new here don't need to tell that osteoarthritis ia a HUGE market but what I don't like is : Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem. You're a biotech company or a company operating in I don't know what. It totally confuse investors.
1 · Reply
Fishin_Fool
Fishin_Fool Aug. 17 at 3:12 PM
$DDD Gross margin fell YoY to 36.4% from 38.1%, which reads bearish but it fell because of hardware mix, not pricing. On a trailing basis GM has gone 33.9% (FY25) >> 35.9% (Q1) >>36.4% (Q2). Graves: "The key to profitability for us is getting our gross margins up. The linkage there is to consumables on the polymer side and metal parts on the metal side… we'll get material pull-through that almost assuredly always follows. In many cases, it's a regulated environment and it has to follow." $ENLV $KOS $HNST $STKH
2 · Reply
TakeWhatYouGet
TakeWhatYouGet Aug. 14 at 3:53 PM
$ENLV out... Have fun Guys
0 · Reply
Sensore
Sensore Aug. 14 at 3:31 PM
0 · Reply
JJRADANO
JJRADANO Aug. 14 at 3:03 PM
$ENLV When is the vote? Looks like there is doubt about vote and/or clinical trial?
1 · Reply
Rickster4retirement
Rickster4retirement Aug. 13 at 10:22 PM
$ENLV Scam
0 · Reply
BullBobo
BullBobo Aug. 13 at 8:20 PM
$ENLV POS
0 · Reply
Sensore
Sensore Aug. 13 at 5:44 PM
0 · Reply
TakeWhatYouGet
TakeWhatYouGet Aug. 13 at 5:43 PM
$ENLV come on any Hope for this Stock, i am Close to.sell....
0 · Reply
Pacho_Unlimited1
Pacho_Unlimited1 Aug. 13 at 5:36 PM
$ENLV WTF!
1 · Reply
waeng
waeng Aug. 13 at 5:33 PM
$ENLV fxck this POS
0 · Reply
Nesabbah
Nesabbah Aug. 12 at 2:50 PM
$ENLV jumped big up then deep down. Mmmm
3 · Reply
TakeWhatYouGet
TakeWhatYouGet Aug. 12 at 12:51 PM
$ENLV still in 😂
0 · Reply
Sensore
Sensore Aug. 11 at 7:44 PM
0 · Reply
MGAP
MGAP Aug. 5 at 1:39 AM
0 · Reply
moneymarker20188
moneymarker20188 Aug. 4 at 8:24 PM
$ENLV I need $10 good enough
1 · Reply
MasterOfMyDomains
MasterOfMyDomains Aug. 4 at 7:05 PM
$ENLV At this pace, how is this ever gonna happen? lol 6:30 AM EDT, August 03, 2026 (Benzinga Newswire) HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and raises the price target from $20 to $80. Write to Benzinga at [email protected]
1 · Reply